TY - JOUR
T1 - Influence of mitochondrial inhibition on global and local [Ca(2+)](I) in rat tail artery.
AU - Swärd, Karl
AU - Dreja, Karl
AU - Lindqvist, Anders
AU - Persson, Erik
AU - Hellstrand, Per
PY - 2002
Y1 - 2002
N2 - Inhibition of oxidative metabolism is often found to decrease contractility of systemic vascular smooth muscle, but not to reduce global [Ca(2+)](i). In the present study, we probe the hypothesis that it is associated with an altered pattern of intracellular Ca(2+) oscillations (waves) influencing force development. In the rat tail artery, mitochondrial inhibitors (rotenone, antimycin A, and cyanide) reduced alpha(1)-adrenoceptor-stimulated force by 50% to 80%, but did not reduce global [Ca(2+)](i). Less relaxation (about 30%) was observed after inhibition of myosin phosphatase activity with calyculin A, suggesting that part of the metabolic sensitivity involves the regulation of myosin 20-kDa light chain phosphorylation, although no decrease in phosphorylation was found in freeze-clamped tissue. Confocal imaging revealed that the mitochondrial inhibitors increased the frequency but reduced the amplitude of asynchronous cellular Ca(2+) waves elicited by alpha(1) stimulation. The altered wave pattern, in association with increased basal [Ca(2+)](i), accounted for the unchanged global [Ca(2+)](i). Inhibition of glycolytic ATP production by arsenate caused similar effects on Ca(2+) waves and global [Ca(2+)](i), developing gradually in parallel with decreased contractility. Inhibition of wave activity by the InsP(3) receptor antagonist 2-APB correlated closely with relaxation. Furthermore, abolition of waves with thapsigargin in the presence of verapamil reduced force by about 50%, despite unaltered global [Ca(2+)](i), suggesting that contraction may at least partly depend on Ca(2+) wave activity. This study therefore indicates that mitochondrial inhibition influences Ca(2+) wave activity, possibly due to a close spatial relationship of mitochondria and the sarcoplasmic reticulum and that this contributes to metabolic vascular relaxation.
AB - Inhibition of oxidative metabolism is often found to decrease contractility of systemic vascular smooth muscle, but not to reduce global [Ca(2+)](i). In the present study, we probe the hypothesis that it is associated with an altered pattern of intracellular Ca(2+) oscillations (waves) influencing force development. In the rat tail artery, mitochondrial inhibitors (rotenone, antimycin A, and cyanide) reduced alpha(1)-adrenoceptor-stimulated force by 50% to 80%, but did not reduce global [Ca(2+)](i). Less relaxation (about 30%) was observed after inhibition of myosin phosphatase activity with calyculin A, suggesting that part of the metabolic sensitivity involves the regulation of myosin 20-kDa light chain phosphorylation, although no decrease in phosphorylation was found in freeze-clamped tissue. Confocal imaging revealed that the mitochondrial inhibitors increased the frequency but reduced the amplitude of asynchronous cellular Ca(2+) waves elicited by alpha(1) stimulation. The altered wave pattern, in association with increased basal [Ca(2+)](i), accounted for the unchanged global [Ca(2+)](i). Inhibition of glycolytic ATP production by arsenate caused similar effects on Ca(2+) waves and global [Ca(2+)](i), developing gradually in parallel with decreased contractility. Inhibition of wave activity by the InsP(3) receptor antagonist 2-APB correlated closely with relaxation. Furthermore, abolition of waves with thapsigargin in the presence of verapamil reduced force by about 50%, despite unaltered global [Ca(2+)](i), suggesting that contraction may at least partly depend on Ca(2+) wave activity. This study therefore indicates that mitochondrial inhibition influences Ca(2+) wave activity, possibly due to a close spatial relationship of mitochondria and the sarcoplasmic reticulum and that this contributes to metabolic vascular relaxation.
KW - Calcium Signaling : drug effects
KW - Calcium : metabolism
KW - Cyanides : pharmacology
KW - Calcium Signaling : physiology
KW - Enzyme Inhibitors : pharmacology
KW - Female
KW - Intracellular Fluid : metabolism
KW - In Vitro
KW - Glycolysis : drug effects
KW - Isometric Contraction : drug effects
KW - Mitochondria : drug effects
KW - Mitochondria : metabolism
KW - Myosin Light Chains : metabolism
KW - Phosphorylation : drug effects
KW - Rats
KW - Sprague-Dawley
KW - Receptors
KW - alpha-1 : metabolism
KW - Adrenergic
KW - Rotenone : pharmacology
KW - Support
KW - Tail : blood supply
KW - Non-U.S. Gov't
KW - Vasoconstriction : drug effects
KW - Arteries : metabolism
KW - Arteries : drug effects
KW - Arsenates : pharmacology
KW - Antimycin A : pharmacology
KW - Macrolide : pharmacology
KW - Antibiotics
KW - Animal
KW - Adrenergic alpha-Agonists : pharmacology
KW - Uncoupling Agents : pharmacology
U2 - 10.1161/01.RES.0000015214.40360.84
DO - 10.1161/01.RES.0000015214.40360.84
M3 - Article
SN - 0009-7330
VL - 90
SP - 792
EP - 799
JO - Circulation Research
JF - Circulation Research
IS - 7
ER -